We use cookies on our website to make it clear, useful and reliable.In order to achieve this and to provide certain personalised features we store a small amount of data about you. To learn more visit Cookies: How we use the information on our website. By navigating from the front page to other sections of our website, you are consenting to information being stored.
Our latest news and events
New research establishes an identifiable genetic component to motor neuron disease for 1 in 4 people with the disease; a significant increase from previous estimates of 1 in 5.
By NIHR Maudsley BRC at 31 Mar 2026
In 2025, NIHR Maudsley BRC delivered research with real-world impact from evaluating new treatments for depression and migraine to developing innovative approaches to monitoring opioid overdose and diagnosing eating disorders.
By NIHR Maudsley BRC at 19 Dec 2025New research from the MIROCALS (Modifying Immune Responses and Outcomes in ALS) clinical trial has found that low-dose interleukin-2 (IL2LD) is both safe and effective for use on people with Motor Neurone Disease (MND), also known as amyotrophic lateral sclerosis (ALS) compared to placebo.
By NIHR Maudsley BRC at 12 May 2025
Last week, members of the All-Party Parliamentary Group (APPG) on Motor Neuron Disease (MND) visited King’s College London to witness firsthand the pioneering research undertaken as part of the UK MND Research Institute’s national collaboration to tackle the disease.
By NIHR Maudsley BRC at 19 Feb 20252024 has been a year of remarkable discoveries and innovative advancements in mental health research, showcasing the expertise of NIHR Maudsley BRC researchers.
By NIHR Maudsley BRC at 13 Dec 2024
The NIHR Maudsley Biomedical Research Centre (BRC) is part of the NIHR and hosted by South London and Maudsley NHS Foundation Trust in partnership with King's College London. We are part of King’s Health Partners.
© NIHR Maudsley Biomedical Research Centre 2026 | Website design by CSMB Design | All rights reserved.
